News

Merck is injecting $1 billion into a new facility in Wilmington, Delaware to amp up U.S. drug production, especially for its ...
U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...
The project, more than a decade in the making, replaces a business campus that was once home to Johnson & Johnson, Pfizer and ...
US pharma giant Merck & Co has started building a $1 billion, 470,000-square-foot biologics center of excellence in ...
Sampled, a fully integrated analytical laboratory and biorepository, has obtained WDA licensing from the UK Medicines and ...
The owners of industrial buildings in Loveland and Windsor have traded those assets in a $19.4 million transaction brokered ...
Despite short-term headwinds due to customer warehouse overbuilds, we believe the pandemic only accelerated the need for automation given the strong secular trend toward e-commerce. Many of ...
Merck (MRK) is reportedly looking to expand its U.S. manufacturing presence with a $1 billion facility in Delaware, becoming ...
New condition monitoring IoT solution enhances supply chain visibility for pharmaceutical companies. SANTA ANA, Calif., /PRNewswire/ -- Identiv, Inc. (NASDAQ: INVE) ...
CEO of AUDA-NEPAD emphasized the potential of the AfCFTA to serve as a cornerstone for building a robust pharmaceutical industry in Africa. Her remarks painted a vivid picture of both the urgency and ...
The Ukrainian Embassy in India has said that Russia's arguments over the attack on the Indian pharma company's warehouse in Kyiv have "no credibility" and It said that Ukraine's Prosecutor General ...
New Delhi [India], April 18 (ANI): The Ukrainian Embassy in India has said that Russia's arguments over the attack on the Indian pharma company's warehouse in Kyiv have "no credibility" and It ...